Researcher Presents Promising Early Results on Color Cascade Testing Uptake at ACMG Meeting

Apr 15, 2018

|

CHARLOTTE, NC (GenomeWeb) – An early analysis of data from the Color Genomics Color Family Testing Program suggests it is possible to get relatively robust uptake of cascade testing for hereditary cancer risk when cost is decreased and access is simplified.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Researcher Presents Promising Early Results on Color Cascade Testing Uptake at ACMG Meeting

To read the full story....

Breaking News

Biden Unveils Economic Plan to Provide $50B for COVID-19 Testing Expansion

Report Details COVID-19 Testing Within Federal Government

In Brief This Week: Thermo Fisher, Yourgene Health, Deep Lens, and More

DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech

FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Featured White Papers

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

What's Popular?

Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

Report Details COVID-19 Testing Within Federal Government

JP Morgan Healthcare Conference 2021, Day One: Roche, Guardant, Hologic, Thermo Fisher, and More

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Sponsorships